Early treatment in migraine: how strong is the current evidence?
about
Zolmitriptan for acute migraine attacks in adultsAspirin with or without an antiemetic for acute migraine headaches in adultsIbuprofen with or without an antiemetic for acute migraine headaches in adultsSumatriptan (intranasal route of administration) for acute migraine attacks in adultsSumatriptan (subcutaneous route of administration) for acute migraine attacks in adultsSumatriptan (oral route of administration) for acute migraine attacks in adultsSumatriptan (rectal route of administration) for acute migraine attacks in adultsIbuprofen with or without an antiemetic for acute migraine headaches in adultsAspirin with or without an antiemetic for acute migraine headaches in adultsEfficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura.Results from a pharmacy-based patient survey on the use of a fixed combination analgesic containing acetylsalicylic acid, paracetamol and caffeine by self-diagnosing and self-treating patientsThe 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.Applying the benefits of the AwM study in the clinic.Almotriptan for the treatment of acute migraine: a review of early intervention trials.Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.Almotriptan: a review of 10 years' clinical experience.What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials? A viewpoint.Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel groConsistency of response to sumatriptan/naproxen sodium in a placebo-controlled cross-over study.
P2860
Q24194592-94527D49-C6F6-4ABA-A805-9498D51C0856Q24197721-81B5C4B6-8928-475C-AA79-CED7F6F211CEQ24197974-55026662-6977-43CB-AEED-CA313FBC455CQ24203640-18884895-12C2-4FAB-8023-9D1589AB36F5Q24203684-1C003530-3A22-45F6-BE09-8D54EBC7FD7EQ24203707-68D4F6C5-24CF-4F31-8F3C-7CA07F1B4943Q24203726-9A970724-AE23-4A6D-A5DF-D701057148C7Q24234446-17518B89-5A1A-4020-AE38-2286E0752324Q24235987-4D470702-E506-48C6-B3DA-DF4359984ED2Q33671824-9E965DD0-88B0-4A66-B94A-8591FE248A28Q37004760-E7199993-E925-4DE9-AAB5-843F915D8832Q37247876-17A4E784-2C38-48AC-8E3E-E7E0FFC12610Q37247878-EF9A7897-DA89-4615-906F-CB75C47F7A2AQ37699415-B54059A4-360C-42EC-97DF-ADA3AF9D7EA2Q37785552-E93E471B-1093-48C9-A000-D56398A60B6FQ37800072-B31018EC-CB19-483A-8A85-D55E1516F58EQ38241125-0028ADD0-8E42-4FE0-88D9-626214F490B2Q39188639-514B04AA-2687-4335-97A5-A88693D1E042Q42882626-F9249041-22D2-4A77-867A-CCF116C7B2CE
P2860
Early treatment in migraine: how strong is the current evidence?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early treatment in migraine: how strong is the current evidence?
@en
Early treatment in migraine: how strong is the current evidence?
@nl
type
label
Early treatment in migraine: how strong is the current evidence?
@en
Early treatment in migraine: how strong is the current evidence?
@nl
prefLabel
Early treatment in migraine: how strong is the current evidence?
@en
Early treatment in migraine: how strong is the current evidence?
@nl
P2860
P1433
P1476
Early treatment in migraine: how strong is the current evidence?
@en
P2093
A Gendolla
P2860
P356
10.1111/J.1468-2982.2008.01688.X
P407
P478
28 Suppl 2
P577
2008-09-01T00:00:00Z